European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
Community Register of medicinal products
List of referrals for human medicinal products
Dexrazoxane
| Product name: | Dexrazoxane |
| Also marketed in the EU under the name(s): | Cardioxane, Cyrdanax, DEXRAZOXANE CYATHUS, Enaxozar, Procard |
| INN: | Dexrazoxane |
| Indication: | Prevention of chronic cumulative cardiotoxicity caused by doxorubicin or epirubicin use in advanced and/or metastatic adult breast cancer patients |
| Marketing Authorisation Holder: | Not available |
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 15/09/2011 | Referral | - | (2011)6519 of 13/09/2011 |